WebOfPharma · Cleaning-validation strategy
Bracketing and Matrixing in Cleaning Validation
A practical, risk-based guide to grouping products and equipment, selecting representative cleaning challenges, designing a defensible study matrix and documenting what the results do—and do not—cover.
A site may manufacture many products on several shared equipment trains. Validating every possible product–equipment combination can be inefficient, but testing only one convenient product may leave important risks unchallenged. Bracketing and matrixing provide structured ways to reduce unnecessary duplication while preserving evidence that the approved cleaning process works across its intended scope.
The key is to design the grouping around the actual cleaning risk. Products can differ in toxicological limit, solubility, adhesion, formulation and campaign load. Equipment can differ in surface area, geometry, seals and cleaning mechanism. These variables do not always point to the same “worst case.” This guide explains how to select representatives, build a matrix, set decision rules and document a rationale that supports Cleaning Validation in Pharmaceuticals and the site's broader cGMP program.
What bracketing means in cleaning validation
Bracketing is a planned strategy in which a selected extreme or representative case is used to support a defined family of related products, equipment or operating conditions. The selected case should challenge the attributes that matter for the family. If the family varies across several independent risk dimensions, one representative may not cover all of them.
Product bracketing
Product bracketing groups products that share a justified cleaning process and have sufficiently comparable residue and risk characteristics. A product at one end of the family may be hardest to remove because it is poorly soluble or sticky. A different product may be most critical because its HBEL or PDE is lower. The site must assess these dimensions together rather than assuming one product is worst for every purpose.
Equipment bracketing
Equipment bracketing groups equipment that has comparable product-contact materials, surface condition, cleaning mechanism, operating range and access. A larger vessel may represent surface area or spray coverage, while a small valve or transfer line may represent difficult access. Similar equipment names alone do not prove that one unit represents another.
Operating-condition bracketing
Operating-condition bracketing challenges the credible extremes of variables such as maximum dirty hold, maximum campaign length, minimum cleaning temperature, lowest validated flow, detergent concentration range or longest clean hold. The protocol should identify which boundaries are challenged and why they represent routine use.
What matrixing means in cleaning validation
Matrixing is a predefined study design that tests selected combinations from a larger set of products, equipment trains, cleaning procedures, sample locations or conditions. The design uses risk and process knowledge to decide which combinations are directly tested and which are represented by the evidence from tested combinations.
Matrixing is not simply skipping tests or testing a few products at random. It requires a clear population of cases, a reason for selecting each tested combination, coverage of relevant extremes, and a rule for how results affect the untested combinations. If the matrix reveals an unexpected result or a significant difference between cases, the grouping should be reassessed and testing expanded.
Bracketing
Choose the extremes
Use a scientifically justified worst-case or representative case to challenge a defined, comparable family.
Matrixing
Choose combinations
Preselect a structured subset from a larger product–equipment–condition set and explain the coverage.
Both methods
Keep scope explicit
State which products, equipment and operating conditions are covered and which are outside the rationale.
Risk control
Expand when needed
Use results, deviations, changes and new knowledge to add testing or narrow the family.
Bracketing versus matrixing: key differences
| Feature | Bracketing | Matrixing |
|---|---|---|
| Primary question | Which extreme case can represent this justified family? | Which combinations from the defined population need direct testing? |
| Typical application | Products with a shared cleaning process; equipment sizes or configurations with clear comparability. | Several products across multiple equipment trains, steps, campaigns or sampling conditions. |
| Study logic | Select worst-case or edge cases that challenge specific variables. | Use a planned pattern that distributes tests across factors and preserves coverage. |
| Main risk | Assuming one “worst” product covers unrelated risk dimensions. | Leaving combinations untested without a credible basis for inference. |
| Evidence needed | Comparability and rationale for the chosen boundary cases. | Matrix design, selection logic, factor coverage and predefined expansion rules. |
| When to expand | When a new product or equipment item falls outside the established family. | When results show variation, interaction or an uncovered risk factor. |
When can a product family be bracketed?
A product family is a candidate for bracketing when the members use the same or demonstrably equivalent cleaning procedure and equipment path, and when their differences can be assessed against defined risk dimensions. The family should be documented in a controlled record and approved before the validation study begins.
Compare more than product names
- Health-based risk: HBEL/PDE/ADE, potency, toxicity, sensitization or other relevant hazards.
- Physical cleanability: solubility, adhesion, oily or tacky behavior, drying, crystallization and degradation.
- Manufacturing load: batch size, maximum dose, campaign length, residue mass and contact area.
- Formulation: binders, pigments, oils, polymers, proteins, preservatives and other excipients that change residue behavior.
- Cleaning process: detergent, concentration, temperature, time, flow, pressure, manual action, rinse sequence and drying.
- Analytical detectability: sample recovery, method specificity, sensitivity, stability and interference.
Use a comparison table or risk assessment to identify which product is extreme for each factor. If Product A has the lowest PDE while Product B has the lowest solubility and Product C forms the hardest film, the site may need more than one representative challenge. A composite score can help prioritize, but it should not conceal a critical risk in one dimension.
When can equipment be bracketed?
Equipment may be grouped when the site demonstrates that the cleaning mechanism and cleanability are comparable. The comparison should include design and use, not just nominal capacity.
| Equipment feature | What to compare | Why it matters |
|---|---|---|
| Product-contact material | Stainless grade, polymer, glass, coating, gasket or seal material | Surface energy, compatibility, residue adhesion and sampling recovery can differ. |
| Geometry and access | Dead legs, ports, welds, valves, transfer lines, impellers and shadowed zones | Some surfaces receive less cleaning action or are difficult to inspect and sample. |
| Surface area and scale | Total product-contact area, aspect ratio, vessel diameter and surface-to-volume relationship | Scale may change coverage, residue distribution and rinse dilution. |
| Cleaning mechanism | CIP spray devices, flow paths, agitation, manual brushing and disassembly | Two units with similar size can have different cleaning forces or coverage. |
| Use pattern | Product sequence, batch load, campaign, dirty hold and maintenance history | Actual usage can change residue load, drying and cleaning performance. |
| Sampling capability | Swab access, rinse path, recovery surface and method suitability | A result from one location may not represent inaccessible surfaces elsewhere. |
For example, two stainless steel tanks may appear similar, but one may have a spray ball and drainable outlet while the other has a long return line, different valve seats and a shadowed baffle. The difficult features may require separate qualification or targeted validation even if the main vessel bodies can be grouped.
How to build a cleaning-validation matrix
Before constructing a matrix, list the full set of relevant combinations. A typical matrix might include products, equipment trains, cleaning procedures, campaign scenarios and analytical sample points. The goal is not to test every possible cell automatically; it is to make the decision about tested and represented cells explicit and reviewable.
Define the population
List all products, equipment trains, cleaning methods, residues, campaign conditions and sample types proposed for coverage.
Establish grouping rules
Document the criteria for product families, equipment families and cleaning-procedure equivalence before selecting tests.
Map risk dimensions
Compare HBEL, solubility, cleanability, load, hold time, surface geometry, cleaning force and analytical detectability.
Select direct challenges
Choose cases that cover each material risk extreme. Add multiple products or equipment items when one representative cannot cover all dimensions.
Check factor interactions
Ask whether a product and equipment combination together creates a greater risk than either factor alone—for example, a sticky residue in a poorly drained line.
Predefine expansion rules
State what results, deviations, trends or changes require testing additional matrix cells or revising the bracket.
Link each cell to evidence
For tested cells, reference protocol data. For represented cells, document the scientific basis and any supporting verification.
Approve before execution
Obtain QA approval of the scope, criteria, rationale, protocol and matrix before collecting validation data.
Worked example: product and equipment grouping
The example below is illustrative. Assume a site uses the same detergent-based cleaning procedure for three oral solid dose products on two granulator trains. The trains differ in vessel size and discharge design. The products share the main API family but have different residue behavior.
| Case | Health-based residue risk | Cleanability challenge | Equipment concern |
|---|---|---|---|
| Product A on Train 1 | Lowest HBEL in the family | Moderately soluble, low adhesion | Small vessel, standard outlet |
| Product B on Train 1 | Higher HBEL | Lowest solubility; residue dries as a film | Small vessel, standard outlet |
| Product C on Train 2 | Intermediate HBEL | Tacky binder; longer planned dirty hold | Larger train with a difficult discharge valve |
A weak design might test only Product A on Train 1 because it has the lowest HBEL. That could challenge the residue limit but would not automatically prove removal of Product B’s poorly soluble film or Product C’s sticky residue from Train 2’s valve. A stronger approach may use Product A for the toxicological limit challenge, Product B for solubility and residue-removal challenge, and Product C on Train 2 for the combined tacky-residue, dirty-hold and equipment-geometry challenge.
After direct challenges demonstrate control, the site may use bracketing to cover similar products and equipment variants if supporting evidence confirms equivalence. Routine cleaning verification or periodic monitoring can strengthen continued confidence, but it should not be used to justify an unsupported initial bracket.
Sample matrix structure
A matrix should make the testing and representation transparent. A simple study map might look like this:
| Product / case | Train 1: standard discharge | Train 2: complex discharge | Reason and coverage |
|---|---|---|---|
| Product A: lowest HBEL | Direct validation | Represented only if justified by surface and process equivalence | Challenges the most restrictive toxicological limit. |
| Product B: lowest solubility | Direct validation | Represented if same residue behavior and cleaning mechanism are demonstrated | Challenges chemical removal and analytical recovery. |
| Product C: tacky residue, longest hold | Not included unless evidence shows comparable challenge | Direct validation | Challenges difficult residue behavior on the hardest equipment location. |
| Other family products | Bracketed after comparative assessment | Separate assessment if design or use differs | Covered only within defined product and equipment family boundaries. |
Acceptance criteria and sampling must still be appropriate
Bracketing and matrixing change the study design; they do not relax acceptance criteria. Each tested case should meet the approved limits for product residue, cleaning-agent residue and microbiological contamination where applicable. Limits should be scientifically justified and linked to the next product, equipment surface area and health-based assessment where relevant.
Sampling should target representative and hard-to-clean locations. Swab and rinse methods have different strengths; the study should justify the chosen method, recovery, area, extraction conditions and analytical sensitivity. If equipment cannot be sampled directly, the rationale for an alternative method should be documented. Ensure sampling locations include the features that define the bracket—not just convenient flat surfaces.
Using risk assessment to defend the approach
A formal risk assessment can structure product and equipment comparisons. A site may use an FMEA, risk-ranking matrix or another approved QRM method. Whatever tool is selected, score definitions should be clear, evidence should support the ratings, and the team should address high severity independently of a numerical composite score.
- Same cleaning procedure or justified procedure equivalence
- Product residue behavior and solubility compared
- HBEL/PDE and toxicological hazards reviewed
- Maximum batch, campaign and dirty-hold cases assessed
- Equipment surface, geometry and cleaning force compared
- Hardest-to-clean sample points represented
- Analytical capability and recovery support chosen samples
- Untested combinations linked to a valid representative case
- Expansion and failure rules set before execution
- Residual risk approved by QA and process owners
Documentation for a defensible bracket or matrix
Keep the rationale in controlled documents that can be followed from the quality plan to the final report. The reader should be able to identify the scope, understand how cases were grouped, see why each representative was selected, and verify what evidence supports coverage.
| Document or record | What it should establish |
|---|---|
| Cleaning validation master plan | Site strategy, equipment/product scope, family logic, responsibilities and lifecycle review. |
| Risk assessment | Product, equipment, cleaning, sampling and analytical variables considered, with rationale for selected extremes. |
| Family or matrix table | Tested cases, represented cases, excluded cases and the reason for each assignment. |
| Approved protocol | Test execution, sampling, analytical method, predefined acceptance limits, deviations and expansion rules. |
| Validation report | Results, deviations, trend or variability assessment, scope supported and limitations of the conclusion. |
| Change-control record | Impact of new products, equipment, detergents, cleaning settings or analytical methods on the established family. |
Records should follow ALCOA+ principles. Preserve raw laboratory data, sample identity, calculations, equipment status and review history. Link controlled cleaning SOPs to the protocol and ensure training is current. Where electronic records or signatures support decisions, assess applicable 21 CFR requirements alongside the site's other obligations.
Qualification supports the cleaning-validation scope
Equipment comparisons are stronger when the qualification package verifies design and operation. Cleanability requirements should be considered early, then confirmed through the appropriate qualification stages.
| Stage | How it supports bracketing | Reference |
|---|---|---|
| Requirements | Define materials, drainability, access, surface finish, cleaning cycles and data needs for comparable units. | URS |
| Design | Compare hygienic design and product-contact features before accepting equipment into one family. | DQ |
| Installation | Verify the installed configuration, materials, utilities, instruments and connections match the approved design. | IQ |
| Operation | Challenge cleaning recipes, alarms, flow, temperature, pressure and operating ranges. | OQ |
| Performance | Confirm the system performs under routine or justified worst-case production conditions. | PQ |
Common mistakes to avoid
| Common mistake | Why it weakens the rationale | Better practice |
|---|---|---|
| Selecting only the lowest-HBEL product | It may not be the hardest residue to remove. | Evaluate toxicological severity and cleanability separately; add challenges for distinct extremes. |
| Grouping equipment by capacity alone | Geometry, spray coverage, drainability and seals can differ. | Compare drawings, surfaces, cleaning mechanism and actual use. |
| Using an informal matrix after testing | It can look like retrospective justification of results. | Predefine the population, selection pattern, criteria and expansion rules. |
| Assuming same detergent means same process | Time, temperature, flow, disassembly and rinse endpoints may differ. | Demonstrate cleaning-cycle equivalence using parameters and performance evidence. |
| Extrapolating a pass to every untested combination | Untested cases may introduce a new risk interaction. | Limit conclusions to the documented family and validate outside cases separately. |
| Failing to revisit the bracket after change | New products or equipment can shift the worst case. | Use change control and periodic review to reassess scope and evidence. |
Change control and lifecycle maintenance
A bracket or matrix is valid only while its assumptions remain true. Reassess when a product's formulation, potency, toxicology, batch size or campaign changes; when new equipment, surfaces, seals or cleaning devices are installed; when detergent or cycle parameters change; or when deviations, trends and maintenance findings indicate reduced performance.
When a change falls outside the approved family, document whether it requires a new risk assessment, additional matrix cells, focused verification, partial revalidation or a separate cleaning validation. If a failure exposes a gap in the family logic, investigate it and implement appropriate CAPA. Link systemic actions with the site's CAPA program, then verify effectiveness.
Audit checklist
- Scope and product/equipment population are complete
- Bracketing and matrixing are defined in site procedures
- Worst-case rationale addresses multiple risk dimensions
- Cleaning procedures are equivalent or separately assessed
- Equipment grouping includes design, use and sampling access
- Tested and represented cases are mapped before execution
- Acceptance limits are independently justified and unchanged
- Sampling and analytical methods cover the residue risks
- Failure, deviation and matrix-expansion rules are predefined
- Change-control triggers and periodic reviews are documented
Key takeaways
01 · Define
Set the population
List every product, equipment train, cleaning process and condition the strategy intends to cover.
02 · Compare
Assess the real risks
Compare health-based limits, residue behavior, equipment geometry, campaign conditions and method capability.
03 · Design
Predefine the matrix
Choose direct challenges and rules for represented cases before protocol execution begins.
04 · Maintain
Review after change
Expand or revise coverage when evidence, deviations or changes alter the worst-case picture.
Frequently asked questions
What is bracketing in cleaning validation?
Bracketing uses a justified worst-case or representative product, equipment item or operating condition to support a defined group of comparable cases.
What is matrixing in cleaning validation?
Matrixing is a preplanned design that tests selected combinations from a larger product–equipment–condition population, with a documented rationale for how the tested evidence represents the rest.
Are bracketing and matrixing explicitly required by GMP?
They are strategies a manufacturer may use when scientifically justified. Regulations and guidance expect effective, documented cleaning validation; the site remains responsible for proving that its design covers the intended scope.
Can one worst-case product represent every product?
Only when evidence shows that the selected product challenges the relevant risk dimensions for the family. A product with the lowest HBEL may not be the least soluble or hardest to clean, so more than one representative may be needed.
Can different equipment sizes be grouped?
Sometimes. Compare geometry, surface area, materials, cleaning mechanism, spray coverage, drainability, access, use pattern and sample locations. Size alone is not enough to establish equivalence.
Does matrixing reduce acceptance criteria?
No. It can reduce duplicate study combinations when justified, but each directly tested case must meet its predefined criteria, and represented cases must remain scientifically covered.
How many matrix combinations should be tested?
There is no universal number. The matrix size depends on the number of risk factors, interactions, products, equipment configurations, prior knowledge and the strength of equivalence evidence.
Should the matrix include every possible combination?
Not necessarily. It should include enough combinations to challenge the important extremes and interactions. Any untested combinations need a clear rationale for representation.
When should a matrix be expanded?
Expand it when a validation failure, unexpected trend, new product, equipment change, cleaning-process change or new risk information shows the original grouping may not cover the case.
How should a bracket or matrix be documented?
Document scope, grouping criteria, risk assessment, tested and represented cases, selected worst cases, protocol links, acceptance criteria, expansion rules, approvals and change-control triggers.
Conclusion
Bracketing and matrixing can make cleaning-validation programs more focused without weakening patient protection. Bracketing selects defensible extremes for a comparable family; matrixing plans which combinations from a larger population will receive direct testing. Both depend on a complete inventory, clear grouping criteria, risk assessment, representative sampling and predefined decision rules.
The practical test is simple: can the site explain why each product and equipment item is directly tested or represented, show that the selected cases challenge the relevant risks, and identify what would trigger additional work? When those answers are documented and maintained through change control, a reduced study design can remain scientifically meaningful and inspection-ready.
.webp)
